Study to Assess PK, Safety and Tolerability in Healthy Subjects
Clinical trial NCT06380699 · COMPLETED
Trial details
- NCT number
- NCT06380699
- Sponsor
- Changzhou Qianhong Bio-pharma Co., Ltd.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-16
- Primary completion
- 2023-11-16
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.